Latest
Yuzu Health Raises $35M Series A to Modernize Health Insurance InfrastructureYuzu Health Raises $35M Series A to Modernize Health Insurance Infrastructure|Coastal Measures Raises $1.2M to Build AI Infrastructure for Ocean and Coastal DataCoastal Measures Raises $1.2M to Build AI Infrastructure for Ocean and Coastal Data|Heartland Business Systems Acquires Applied Tech Solutions to Expand Managed IT PlatformHeartland Business Systems Acquires Applied Tech Solutions to Expand Managed IT Platform|Noon Raises $44M Seed to Merge Design and Code into a Unified AI Workflow LayerNoon Raises $44M Seed to Merge Design and Code into a Unified AI Workflow Layer|Supplier.io Acquires TealBook to Strengthen Supplier Data InfrastructureSupplier.io Acquires TealBook to Strengthen Supplier Data Infrastructure|Stipple Bio Emerges with $100M Series A to Build Epitope-Level Cancer TherapiesStipple Bio Emerges with $100M Series A to Build Epitope-Level Cancer Therapies|Ridge AI Raises $2.6M Pre-Seed to Accelerate Real-Time Data Intelligence for B2B SoftwareRidge AI Raises $2.6M Pre-Seed to Accelerate Real-Time Data Intelligence for B2B Software|Apnimed Secures Up to $150M Credit Facility to Advance Oral Sleep Apnea TherapyApnimed Secures Up to $150M Credit Facility to Advance Oral Sleep Apnea Therapy|Beacon Biosignals Extends Series B to $97M for AI-Driven Brain Data PlatformBeacon Biosignals Extends Series B to $97M for AI-Driven Brain Data Platform|Neurocrine Biosciences Acquires Soleno Therapeutics in $2.9B DealNeurocrine Biosciences Acquires Soleno Therapeutics in $2.9B Deal|Yuzu Health Raises $35M Series A to Modernize Health Insurance InfrastructureYuzu Health Raises $35M Series A to Modernize Health Insurance Infrastructure|Coastal Measures Raises $1.2M to Build AI Infrastructure for Ocean and Coastal DataCoastal Measures Raises $1.2M to Build AI Infrastructure for Ocean and Coastal Data|Heartland Business Systems Acquires Applied Tech Solutions to Expand Managed IT PlatformHeartland Business Systems Acquires Applied Tech Solutions to Expand Managed IT Platform|Noon Raises $44M Seed to Merge Design and Code into a Unified AI Workflow LayerNoon Raises $44M Seed to Merge Design and Code into a Unified AI Workflow Layer|Supplier.io Acquires TealBook to Strengthen Supplier Data InfrastructureSupplier.io Acquires TealBook to Strengthen Supplier Data Infrastructure|Stipple Bio Emerges with $100M Series A to Build Epitope-Level Cancer TherapiesStipple Bio Emerges with $100M Series A to Build Epitope-Level Cancer Therapies|Ridge AI Raises $2.6M Pre-Seed to Accelerate Real-Time Data Intelligence for B2B SoftwareRidge AI Raises $2.6M Pre-Seed to Accelerate Real-Time Data Intelligence for B2B Software|Apnimed Secures Up to $150M Credit Facility to Advance Oral Sleep Apnea TherapyApnimed Secures Up to $150M Credit Facility to Advance Oral Sleep Apnea Therapy|Beacon Biosignals Extends Series B to $97M for AI-Driven Brain Data PlatformBeacon Biosignals Extends Series B to $97M for AI-Driven Brain Data Platform|Neurocrine Biosciences Acquires Soleno Therapeutics in $2.9B DealNeurocrine Biosciences Acquires Soleno Therapeutics in $2.9B Deal
Back to articles
Jesse Landry

Ares Management Raises $9.8B+ for Opportunistic Credit Strategy

Funding Details

Amount

$9.8B+

Capital gets raised every day. Most of it makes a little noise, does its job, and moves on. Then you get a raise like this, and the room shifts before anyone says a word. Ares Management just pulled in over $9.8B for its Opportunistic Credit strategy, with Ares Special Opportunities Fund III clocking more than $8.3B in equity commitments. That is not a tiptoe into the market. That is a full-body entrance, tailored suit, no introduction needed.

Respect where it’s due. Antony Ressler, Bennett Rosenthal, John Kissick, and CEO Michael Arougheti did not just build a firm. They built a machine that knows when the market gets shaky, liquidity gets scarce, and everyone else starts checking exits. That is when Ares leans in, writes the check, and structures the deal nobody else can quite price.

Opportunistic Credit sounds polite. It isn’t. This is the part of the market where things are a little bent, a little stressed, sometimes misunderstood, and occasionally mispriced. Translation: opportunity if you have the stomach and the structure. Ares has both. They sit right in that gap between traditional lending and private equity, where banks hesitate and buyout shops want control. Ares does neither. They provide capital that moves like water and hits like concrete.

More than $17B deployed and over $11B realized since inception tells you this is not a theory. This is reps. This is pattern recognition at scale. When volatility shows up, most players call it risk. Ares calls it inventory.

And let’s talk about timing without pretending it’s luck. Bank disintermediation, tighter lending standards, global uncertainty… the usual cocktail. Middle market companies still need capital to grow, refinance, or just breathe. Ares shows up with options that are not boxed into one lane. Debt, equity, hybrid structures. Public to private. Flexible is an understatement. It is capital that adapts mid-conversation.

The quiet flex here is not just the size of the fund. It is the signal. Global institutional investors lined up without needing a roll call in the press release. When that much capital commits without name-dropping, you are looking at trust built over cycles, not quarters.

For founders and operators watching this from the sidelines, there is a lesson hiding in plain sight. Access to capital is one thing. Access to the right kind of capital, at the right moment, structured the right way, is everything. The winners are not just raising money. They are aligning with partners who understand complexity without charging panic tax. Ares is not chasing headlines. They are underwriting moments most people avoid. And in this market, that might be the cleanest edge on the board.